FDA Inspection
Stream2Sea, LLCStream2Sea, LLC – FDA Inspection, Jul 18, 2019
Record Details
This FDA Inspection record concerns Stream2Sea, LLC, with an inspection on July 18, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 6d5d279e-ddc5-48c9-91ca-67830b325023
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1096665
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.84(e)Rejecting When Specifications Not Met
- 21 CFR 211.188(b)(8)Labeling Control Records and Label Copies
- 21 CFR 211.22(a)Contract drug products--lack of responsibility
- 21 CFR 211.184(d)Labeling: documentation of exam and review
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Stream2Sea, LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2025 | Not classified | Florida District Office | Drug Quality Assurance |
Other documents for Stream2Sea, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.